Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on August 27, 2007

Circulation. 2007
Published online before print August 27, 2007, doi: 10.1161/CIRCULATIONAHA.106.684704
A more recent version of this article appeared on September 18, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
116/12/1404    most recent
CIRCULATIONAHA.106.684704v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Babaev, V. R.
Right arrow Articles by Linton, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Babaev, V. R.
Right arrow Articles by Linton, M. F.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Lipids
Right arrow Pathophysiology
Right arrow Genetically altered mice

Submitted on December 15, 2006
Accepted on July 12, 2007

Macrophage Expression of Peroxisome Proliferator–Activated Receptor-{alpha} Reduces Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice

Vladimir R. Babaev PhD*, Hiroyuki Ishiguro MD, Lei Ding BA, Patricia G. Yancey PhD, Dwayne E. Dove MD, PhD, William J. Kovacs MD, Clay F. Semenkovich MD, Sergio Fazio MD, PhD*, and MacRae F. Linton MD*

From the Department of Medicine (V.R.B., H.I., L.D., P.G.Y., D.E.D., S.F., M.F.L.), Pathology (S.F.), and Pharmacology (M.F.L.), Vanderbilt University Medical Center, Nashville, Tenn; Division of Endocrinology and Metabolism (W.J.K.), University of Texas, Dallas, Tex; and Washington University (C.F.S.), St. Louis, Mo.

* To whom correspondence should be addressed. E-mail: vladimir.babaev{at}vanderbilt.edu or sergio.fazio{at}vanderbilt.edu or macrae.linton{at}vanderbilt.edu.

Background—The peroxisome proliferator–activated receptor-{alpha} (PPAR{alpha}) plays important roles in lipid metabolism, inflammation, and atherosclerosis. PPAR{alpha} ligands have been shown to reduce cardiovascular events in high-risk subjects. PPAR{alpha} expression by arterial cells, including macrophages, may exert local antiatherogenic effects independent of plasma lipid changes.

Methods and Results—To examine the contribution of PPAR{alpha} expression by bone marrow–derived cells in atherosclerosis, male and female low-density lipoprotein receptor–deficient (LDLR-/-) mice were reconstituted with bone marrow from PPAR{alpha}-/- or PPAR{alpha}+/+ mice and challenged with a high-fat diet. Although serum lipids and lipoprotein profiles did not differ between the groups, the size of atherosclerotic lesions in the distal aorta of male and female PPAR{alpha}-/-->LDLR-/- mice was significantly increased (44% and 46%, respectively) compared with controls. Male PPAR{alpha}-/-->LDLR-/- mice also had larger (44%) atherosclerotic lesions in the proximal aorta than male PPAR{alpha}+/+->LDLR-/- mice. Peritoneal macrophages from PPAR{alpha}-/- mice had increased uptake of oxidized LDL and decreased cholesterol efflux. PPAR{alpha}-/- macrophages had lower levels of scavenger receptor B type I and ABCA1 protein expression and an accelerated response of nuclear factor-{kappa}B–regulated inflammatory genes. A laser capture microdissection analysis verified suppressed scavenger receptor B type I and increased nuclear factor-{kappa}B gene expression levels in vivo in atherosclerotic lesions of PPAR{alpha}-/-->LDLR-/- mice compared with the lesions of control PPAR{alpha}+/+->LDLR-/- mice.

Conclusions—These data demonstrate that PPAR{alpha} expression by macrophages has antiatherogenic effects via modulation of cell cholesterol trafficking and inflammatory activity.


Key words: atherosclerosis • macrophages • proteins • receptors




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
A. Amoruso, C. Bardelli, L. G. Fresu, A. Palma, M. Vidali, V. Ferrero, F. Ribichini, C. Vassanelli, and S. Brunelleschi
Enhanced Peroxisome Proliferator-Activated Receptor-{gamma} Expression in Monocyte/Macrophages from Coronary Artery Disease Patients and Possible Gender Differences
J. Pharmacol. Exp. Ther., November 1, 2009; 331(2): 531 - 538.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
L. Piqueras, M. J. Sanz, M. Perretti, E. Morcillo, L. Norling, J. A. Mitchell, Y. Li, and D. Bishop-Bailey
Activation of PPAR{beta}/{delta} inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine release
J. Leukoc. Biol., July 1, 2009; 86(1): 115 - 122.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. Rigamonti, G. Chinetti-Gbaguidi, and B. Staels
Regulation of Macrophage Functions by PPAR-{alpha}, PPAR-{gamma}, and LXRs in Mice and Men
Arterioscler Thromb Vasc Biol, June 1, 2008; 28(6): 1050 - 1059.
[Abstract] [Full Text] [PDF]